FDA Inspection 1210858 - Apellis Pharmaceuticals, Inc. - July 14, 2023

Record Details

This FDA Inspection record concerns Apellis Pharmaceuticals, Inc., with an inspection on July 14, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Apellis Pharmaceuticals, Inc.
Inspection Date: July 14, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · df07be3a-3241-4441-add0-8dac09ab5b36